Q3 2016 EPS Estimates for Humana Inc. Raised by Analyst (HUM)
Humana Inc. (NYSE:HUM) – Equities researchers at Leerink Swann raised their Q3 2016 earnings per share (EPS) estimates for Humana in a report issued on Monday. Leerink Swann analyst A. Gupte now forecasts that the brokerage will post earnings of $3.15 per share for the quarter, up from their prior forecast of $2.85. Leerink Swann currently has a “Outperform” rating on the stock. Leerink Swann also issued estimates for Humana’s Q4 2016 earnings at $2.20 EPS, FY2016 earnings at $9.50 EPS, FY2018 earnings at $12.50 EPS and FY2019 earnings at $14.00 EPS.
A number of other brokerages also recently commented on HUM. Zacks Investment Research upgraded Humana from a “hold” rating to a “buy” rating and set a $198.00 target price for the company in a research note on Tuesday, October 4th. Credit Suisse Group AG reiterated a “hold” rating on shares of Humana in a research report on Tuesday, June 28th. Cantor Fitzgerald reiterated a “buy” rating on shares of Humana in a research report on Saturday, July 9th. Royal Bank Of Canada boosted their price objective on Humana from $220.00 to $224.00 and gave the stock an “outperform” rating in a research report on Friday, July 22nd. Finally, Wolfe Research upgraded Humana to an “outperform” rating and set a $192.00 price objective for the company in a research report on Thursday, July 21st. Seven research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. The stock currently has an average rating of “Buy” and a consensus price target of $200.50.
Shares of Humana (NYSE:HUM) traded up 2.27% during midday trading on Tuesday, reaching $173.75. 407,292 shares of the company’s stock traded hands. The firm has a market cap of $25.90 billion, a PE ratio of 26.69 and a beta of 0.90. Humana has a 52-week low of $150.00 and a 52-week high of $191.65. The company has a 50 day moving average of $175.73 and a 200 day moving average of $175.51.
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at https://www.americanbankingnews.com/2016/10/18/q3-2016-eps-estimates-for-humana-inc-raised-by-analyst-hum.html
Humana (NYSE:HUM) last issued its quarterly earnings results on Wednesday, August 3rd. The insurance provider reported $2.30 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.23 by $0.07. Humana had a net margin of 1.76% and a return on equity of 11.11%. The firm had revenue of $14 billion for the quarter, compared to analyst estimates of $13.59 billion. During the same period in the previous year, the business earned $1.67 EPS. The company’s revenue was up 2.0% compared to the same quarter last year.
The company also recently announced a quarterly dividend, which will be paid on Friday, October 28th. Shareholders of record on Thursday, October 13th will be paid a dividend of $0.29 per share. This represents a $1.16 annualized dividend and a yield of 0.68%. The ex-dividend date is Tuesday, October 11th. Humana’s dividend payout ratio (DPR) is currently 18.18%.
Hedge funds have recently made changes to their positions in the stock. Vanguard Group Inc. increased its stake in shares of Humana by 2.5% in the second quarter. Vanguard Group Inc. now owns 8,964,492 shares of the insurance provider’s stock valued at $1,612,532,000 after buying an additional 219,311 shares during the period. BlackRock Institutional Trust Company N.A. boosted its position in Humana by 3.2% in the second quarter. BlackRock Institutional Trust Company N.A. now owns 3,908,027 shares of the insurance provider’s stock valued at $702,976,000 after buying an additional 120,720 shares in the last quarter. Arrowgrass Capital Partners US LP boosted its position in Humana by 1.8% in the first quarter. Arrowgrass Capital Partners US LP now owns 2,878,848 shares of the insurance provider’s stock valued at $526,685,000 after buying an additional 51,267 shares in the last quarter. Evercore Trust Company N.A. boosted its position in Humana by 3.0% in the second quarter. Evercore Trust Company N.A. now owns 2,570,366 shares of the insurance provider’s stock valued at $462,357,000 after buying an additional 75,126 shares in the last quarter. Finally, BlackRock Fund Advisors boosted its position in Humana by 2.5% in the second quarter. BlackRock Fund Advisors now owns 2,074,281 shares of the insurance provider’s stock valued at $373,122,000 after buying an additional 51,378 shares in the last quarter. 93.27% of the stock is currently owned by institutional investors.
Humana Company Profile
Humana Inc is a health and well-being company. The Company’s segments include Retail, Group, Healthcare Services and Other Businesses. The Retail segment consists of Medicare benefits, marketed to individuals or directly via group accounts, as well as individual commercial fully-insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.
Receive News & Ratings for Humana Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc. and related companies with MarketBeat.com's FREE daily email newsletter.